Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(37 sites)
United States
Dren Investigational Site, Birmingham, Alabama Dren Investigational Site, Duarte, California Dren Investigational Site, Irvine, California Dren Investigational Site, Redwood City, California Dren Investigational Site, New Haven, Connecticut